| G-protein–coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor E Kostenis, G Milligan, A Christopoulos, CF Sanchez-Ferrer, ... Circulation 111 (14), 1806-1813, 2005 | 539 | 2005 |
| Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: a prospective, multicenter observational study using mRNA-1273 or BNT162b2 … J Stumpf, T Siepmann, T Lindner, C Karger, J Schwöbel, L Anders, ... The Lancet Regional Health–Europe 9, 2021 | 284 | 2021 |
| Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents F Gembardt, A Sterner-Kock, H Imboden, M Spalteholz, F Reibitz, ... Peptides 26 (7), 1270-1277, 2005 | 252 | 2005 |
| The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension F Gembardt, C Bartaun, N Jarzebska, E Mayoux, VT Todorov, ... American Journal of Physiology-Renal Physiology 307 (3), F317-F325, 2014 | 227 | 2014 |
| Dysfunction of the key ferroptosis-surveilling systems hypersensitizes mice to tubular necrosis during acute kidney injury W Tonnus, C Meyer, C Steinebach, A Belavgeni, A von Mässenhausen, ... Nature communications 12 (1), 4402, 2021 | 139 | 2021 |
| Angiotensin-(1–7) protects from experimental acute lung injury N Klein, F Gembardt, S Supé, SM Kaestle, H Nickles, L Erfinanda, X Lei, ... Critical Care Medicine 41 (11), e334-e343, 2013 | 126 | 2013 |
| Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function C Peiró, S Vallejo, F Gembardt, V Azcutia, S Heringer-Walther, ... Journal of hypertension 25 (12), 2421-2425, 2007 | 106 | 2007 |
| Successive action of meprin A and neprilysin catabolizes B-type natriuretic peptide K Pankow, Y Wang, F Gembardt, E Krause, X Sun, G Krause, ... Circulation research 101 (9), 875-882, 2007 | 97 | 2007 |
| Angiotensin metabolites can stimulate receptors of the Mas-related genes family F Gembardt, S Grajewski, M Vahl, HP Schultheiss, T Walther Molecular and cellular biochemistry 319, 115-123, 2008 | 94 | 2008 |
| Angiotensin-(1–7) stimulates hematopoietic progenitor cells in vitro and in vivo S Heringer-Walther, K Eckert, SM Schumacher, L Uharek, ... haematologica 94 (6), 857, 2009 | 93 | 2009 |
| Cardiac phenotype and angiotensin II levels in AT1a, AT1b, and AT2 receptor single, double, and triple knockouts JHM Van Esch, F Gembardt, A Sterner-Kock, S Heringer-Walther, TH Le, ... Cardiovascular research 86 (3), 401-409, 2010 | 91 | 2010 |
| Cellular and humoral immune responses after 3 doses of BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant J Stumpf, W Tonnus, A Paliege, R Rettig, A Steglich, F Gembardt, ... Transplantation 105 (11), e267-e269, 2021 | 78 | 2021 |
| Central angiotensin II controls alcohol consumption via its AT1 receptor B Maul, W Krause, K Pankow, M Becker, F Gembardt, N Alenina, ... The FASEB journal 19 (11), 1474-1481, 2005 | 63 | 2005 |
| Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors F Gembardt, S Heringer-Walther, JHM van Esch, A Sterner-Kock, ... The FASEB Journal 22 (8), 3068-3077, 2008 | 48 | 2008 |
| Renal vasoconstrictor and pressor responses to angiotensin IV in mice are AT1a-receptor mediated R Yang, T Walther, F Gembardt, I Smolders, P Vanderheyden, AL Albiston, ... Journal of hypertension 28 (3), 487-494, 2010 | 45 | 2010 |
| New function for an old enzyme: NEP deficient mice develop late-onset obesity M Becker, WE Siems, R Kluge, F Gembardt, HP Schultheiss, M Schirner, ... PloS one 5 (9), e12793, 2010 | 41 | 2010 |
| Therapeutic time window for angiotensin‐(1–7) in acute lung injury S Supé, F Kohse, F Gembardt, WM Kuebler, T Walther British journal of pharmacology 173 (10), 1618-1628, 2016 | 39 | 2016 |
| The clinical relevance of necroinflammation—highlighting the importance of acute kidney injury and the adrenal glands W Tonnus, F Gembardt, M Latk, S Parmentier, C Hugo, SR Bornstein, ... Cell Death & Differentiation 26 (1), 68-82, 2019 | 38 | 2019 |
| Complete blockade of the vasorelaxant effects of angiotensin‐(1–7) and bradykinin in murine microvessels by antagonists of the receptor Mas C Peiro, S Vallejo, F Gembardt, E Palacios, S Novella, V Azcutia, ... The Journal of Physiology 591 (9), 2275-2285, 2013 | 37 | 2013 |
| Relation of ANP and BNP to their N‐terminal fragments in fetal circulation: evidence for enhanced neutral endopeptidase activity and resistance of BNP to neutral endopeptidase … T Walther, H Stepan, K Pankow, F Gembardt, R Faber, HP Schultheiss, ... BJOG: An International Journal of Obstetrics & Gynaecology 111 (5), 452-455, 2004 | 29 | 2004 |
Thomas WaltherProfessor in PharmacologyVerified email at ucc.ie
